When Will Neuralink Be Available to the Public?
Neuralink is in clinical trials for eligible patients and is not sold to the public.
Available now: trials and the patient registry
Eligible people can apply through Neuralink's trials page and patient registry.
Neuralink trials / patient registry
Not for sale commercially
Investigational devices used in studies such as PRIME are not a commercial consumer product. Public availability today means trial access for people who qualify.
Progress so far
Neuralink reported 21 participants ("Neuralnauts") on January 28, 2026. Neura Pod's patient table counted 27+ publicly identified patients as of June 2026. The implant is not sold to the public; access is through Neuralink's clinical trials and patient registry.
Those figures describe research progress. Neuralink has not announced a date for FDA approval of commercial sales.
Forecasts and projections
Third-party forecasts, such as claims of a 2028 launch, are estimates and are separate from any FDA approval. Internal projections reported by Bloomberg in July 2025 targeted approval of the Telepathy device by 2029.
Related guides
- Neuralink Clinical Trials: Eligibility and Compensation
- How Much Does Neuralink Cost?
- How Does Neuralink Work?
- Neuralink FAQ
- Neuralink Patient List
FAQ
Can the public buy Neuralink today?
No. The implant is investigational and is not sold to the public.
When will FDA approve commercial sales?
Neuralink has not announced a date for FDA approval of commercial sales. Watch official Neuralink and regulatory announcements.
